Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2021 Oct 21;11(1):20837.
doi: 10.1038/s41598-021-99952-z.

Vitamin D-related polymorphisms and vitamin D levels as risk biomarkers of COVID-19 disease severity

Affiliations
Multicenter Study

Vitamin D-related polymorphisms and vitamin D levels as risk biomarkers of COVID-19 disease severity

Ana Teresa Freitas et al. Sci Rep. .

Abstract

Vitamin D is a fundamental regulator of host defences by activating genes related to innate and adaptive immunity. Previous research shows a correlation between the levels of vitamin D in patients infected with SARS-CoV-2 and the degree of disease severity. This work investigates the impact of the genetic background related to vitamin D pathways on COVID-19 severity. For the first time, the Portuguese population was characterized regarding the prevalence of high impact variants in genes associated with the vitamin D pathways. This study enrolled 517 patients admitted to two tertiary Portuguese hospitals. The serum concentration of 25 (OH)D, was measured in the hospital at the time of patient admission. Genetic variants, 18 variants, in the genes AMDHD1, CYP2R1, CYP24A1, DHCR7, GC, SEC23A, and VDR were analysed. The results show that polymorphisms in the vitamin D binding protein encoded by the GC gene are related to the infection severity (p = 0.005). There is an association between vitamin D polygenic risk score and the serum concentration of 25 (OH)D (p = 0.04). There is an association between 25 (OH)D levels and the survival and fatal outcomes (p = 1.5e-4). The Portuguese population has a higher prevalence of the DHCR7 RS12785878 variant when compared with its prevalence in the European population (19% versus 10%). This study shows a genetic susceptibility for vitamin D deficiency that might explain higher severity degrees in COVID-19 patients. These results reinforce the relevance of personalized strategies in the context of viral diseases.Trial registration: NCT04370808.

PubMed Disclaimer

Conflict of interest statement

All authors affiliated with the company HeartGenetics, Genetics and Biotechnology SA, declare that the company developed a genetic test, the MyVitDGenes®, that was used to evaluate all the polymorphisms under analysis in this work. All other authors have declared that no conflict of interest exists.

Figures

Figure 1
Figure 1
PRSs are represented as a continuous value. Patients were divided in three groups (Deficient—red; Insufficient—yellow; Sufficient—blue) considering its vitamin D level (a continuous variable). In each group, patients are sorted in ascending order of PRSs.
Figure 2
Figure 2
Vitamin D level (ng/mL) (continuous) and COVID-19 disease severity (binomial: survived, dead).
Figure 3
Figure 3
Comparison of the impact genotypes’ frequency in the Portuguese and European populations. Circles highlight the risk genotype. The red circles show the risk genotypes from variants with a statistically significant difference between these two populations (p-value = 2.5e−7 for DHCR7 RS12785878, and p-value = 2.8e−4 for AMDHD1 RS10745742).

References

    1. Coperchini F, et al. The cytokine storm in COVID-19: An overview of the involvement of the chemokine/chemokine-receptor system. Cytokine Growth Factor Rev. 2020;53:25–32. doi: 10.1016/j.cytogfr.2020.05.003. - DOI - PMC - PubMed
    1. Daneshkhah A, et al. Evidence for possible association of vitamin D status with cytokine storm and unregulated inflammation in COVID-19 patients. Aging Clin. Exp. Res. 2020;32(10):2141–2158. doi: 10.1007/s40520-020-01677-y. - DOI - PMC - PubMed
    1. Aranow C. Vitamin D and the immune system. J. Investig. Med. 2011;59(6):881–886. doi: 10.2310/JIM.0b013e31821b8755. - DOI - PMC - PubMed
    1. Slominski R, et al. COVID-19 and Vitamin D: A lesson from the skin. Exp. Dermatol. 2020;29(9):885–890. doi: 10.1111/exd.14170. - DOI - PMC - PubMed
    1. Afzal S, et al. Vitamin D, hypertension, and ischemic stroke in 116 655 individuals from the general population: A genetic study. Hypertens. 2017;70(3):499–507. doi: 10.1161/HYPERTENSIONAHA.117.09411. - DOI - PubMed

Publication types

MeSH terms

Associated data